MedPath

Impact of Previous Open Renal Surgery on Percutaneous Nephrolithotomy Complications

Completed
Conditions
Open Renal Surgery
Percutaneous Nephrolithotomy
Complications
Registration Number
NCT07097883
Lead Sponsor
Sohag University
Brief Summary

This study compared percutaneous nephrolithotomy (PCNL) complications in cases with or without previous renal surgery.

Detailed Description

Percutaneous nephrolithotomy (PCNL) is a cornerstone in managing large renal calculi. However, in patients with a history of previous open renal surgery (POS), retroperitoneal scarring, altered anatomy, and vascular complications may influence PCNL outcomes.

The literature remains inconsistent regarding whether POS negatively impacts PCNL success or increases complications. Therefore, this study aims to clarify the comparative safety and efficacy of PCNL in patients with and without prior open renal surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Adult patients (≥18 years).
  • Both sexes.
  • Undergoing percutaneous nephrolithotomy (PCNL) for renal calculi >2 cm.
Exclusion Criteria
  • Active urinary tract infection.
  • Elevated serum creatinine >2.0 mg/dL.
  • Pregnancy.
  • Uncontrolled coagulopathy.
  • Significant cardiopulmonary comorbidities.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hospital stay durationTill the discharge from hospital (Up to two weeks)

Lenght of hospital stay was recorded from the admission till the discharge from hospital.

Secondary Outcome Measures
NameTimeMethod
Serum creatinine levelPreoperatively

Serum creatinine level was recorded.

Incidence of patients who need for auxiliary procedure24 hours postoperatively

Incidence of patients who need for auxiliary procedure were recorded.

Trial Locations

Locations (1)

Sohag University

🇪🇬

Sohag, Egypt

Sohag University
🇪🇬Sohag, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.